On August 30, 2018, Kainos Medicine, Inc. (XKON:A220250) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,915 KRW | +0.51% | +40.03% | +13.77% |
2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
+13.77% | 101M | |
+23.37% | 47.02B | |
+49.67% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- A284620 Stock
- News Kainos Medicine, Inc.
- Kainos Medicine, Inc. announced that it has received KRW 2.9999934 billion in funding from DSC Investment Inc.